Business Description
Lepu Medical Technology (Beijing) Co Ltd
ISIN : US52678P2056
Share Class Description:
FRA:07Z0: GDR - Reg SCompare
Compare
Traded in other countries / regions
300003.ChinaLEPU.Switzerland07Z0.Germany IPO Date
2022-10-07Description
Lepu Medical Technology (Beijing) Co Ltd is a China-based company. It specialized in developing, manufacturing and marketing the high-tech medical devices and equipment. The company is engaged in the fields of cardiovascular interventions, structural heart diseases, cardiac rhythm management, anesthesia and critical care, in vitro diagnostics and general surgery. It operates in more than 80 countries.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.87 | |||||
Equity-to-Asset | 0.64 | |||||
Debt-to-Equity | 0.31 | |||||
Debt-to-EBITDA | 3.17 | |||||
Interest Coverage | 9.94 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.48 | |||||
Beneish M-Score | -2.21 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.8 | |||||
3-Year EBITDA Growth Rate | -9.3 | |||||
3-Year EPS without NRI Growth Rate | -8.8 | |||||
3-Year FCF Growth Rate | -54.7 | |||||
3-Year Book Growth Rate | 15.8 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
12-1 Month Momentum % | 2.92 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.62 | |||||
Quick Ratio | 2.01 | |||||
Cash Ratio | 1.2 | |||||
Days Inventory | 321.85 | |||||
Days Sales Outstanding | 88.9 | |||||
Days Payable | 148.31 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 19.5 | |||||
3-Year Average Share Buyback Ratio | -1.4 | |||||
Shareholder Yield % | 1.56 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 64.04 | |||||
Operating Margin % | 22.56 | |||||
Net Margin % | 15.31 | |||||
FCF Margin % | 6.54 | |||||
ROE % | 7.14 | |||||
ROA % | 4.59 | |||||
ROIC % | 7.59 | |||||
ROC (Joel Greenblatt) % | 21.98 | |||||
ROCE % | 7.62 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 22.81 | |||||
PE Ratio without NRI | 20.16 | |||||
Shiller PE Ratio | 18.57 | |||||
Price-to-Owner-Earnings | 52.94 | |||||
PEG Ratio | 7.75 | |||||
PS Ratio | 3.5 | |||||
PB Ratio | 1.61 | |||||
Price-to-Tangible-Book | 2.65 | |||||
Price-to-Free-Cash-Flow | 53.35 | |||||
Price-to-Operating-Cash-Flow | 20.63 | |||||
EV-to-EBIT | 16.91 | |||||
EV-to-EBITDA | 16.91 | |||||
EV-to-Revenue | 3.62 | |||||
EV-to-FCF | 55.46 | |||||
Price-to-Projected-FCF | 1.07 | |||||
Price-to-DCF (Earnings Based) | 6.38 | |||||
Price-to-DCF (FCF Based) | 19.32 | |||||
Price-to-Median-PS-Value | 0.42 | |||||
Price-to-Graham-Number | 1.54 | |||||
Price-to-Net-Current-Asset-Value | 54.23 | |||||
Earnings Yield (Greenblatt) % | 5.91 | |||||
FCF Yield % | 1.85 | |||||
Forward Rate of Return (Yacktman) % | 1.22 |